Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Erratum: Author Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection.

Duthie MS, Pena MT, Ebenezer GJ, Gillis TP, Sharma R, Cunningham K, Polydefkis M, Maeda Y, Makino M, Truman RW, Reed SG.

NPJ Vaccines. 2018 May 15;3:18. doi: 10.1038/s41541-018-0055-7. eCollection 2018.

2.

LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection.

Duthie MS, Pena MT, Ebenezer GJ, Gillis TP, Sharma R, Cunningham K, Polydefkis M, Maeda Y, Makino M, Truman RW, Reed SG.

NPJ Vaccines. 2018 Mar 28;3:12. doi: 10.1038/s41541-018-0050-z. eCollection 2018. Erratum in: NPJ Vaccines. 2018 May 15;3:18.

3.

Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.

Coppola M, van den Eeden SJF, Robbins N, Wilson L, Franken KLMC, Adams LB, Gillis TP, Ottenhoff THM, Geluk A.

Front Immunol. 2018 Feb 26;9:308. doi: 10.3389/fimmu.2018.00308. eCollection 2018. Review.

4.

Nitazoxanide is active against Mycobacterium leprae.

Bailey MA, Na H, Duthie MS, Gillis TP, Lahiri R, Parish T.

PLoS One. 2017 Aug 29;12(8):e0184107. doi: 10.1371/journal.pone.0184107. eCollection 2017.

5.

Symposium Report: Developing Strategies to Block the Transmission of Leprosy.

Mensah-Awere D, Bratschi MW, Steinmann P, Fairley JK, Gillis TP.

Lepr Rev. 2015 Jun;86(2):156-64. No abstract available. Erratum in: Lepr Rev. 2015 Sep;86(3):301.

PMID:
26502686
6.

Current knowledge on Mycobacterium leprae transmission: a systematic literature review.

Bratschi MW, Steinmann P, Wickenden A, Gillis TP.

Lepr Rev. 2015 Jun;86(2):142-55. Review.

PMID:
26502685
7.
8.

Molecular assays for determining Mycobacterium leprae viability in tissues of experimentally infected mice.

Davis GL, Ray NA, Lahiri R, Gillis TP, Krahenbuhl JL, Williams DL, Adams LB.

PLoS Negl Trop Dis. 2013 Aug 22;7(8):e2404. doi: 10.1371/journal.pntd.0002404. eCollection 2013.

9.

Drug resistance in patients with leprosy in the United States.

Williams DL, Lewis C, Sandoval FG, Robbins N, Keas S, Gillis TP, Scollard DM.

Clin Infect Dis. 2014 Jan;58(1):72-3. doi: 10.1093/cid/cit628. Epub 2013 Sep 24.

PMID:
24065328
10.

Drug-resistant leprosy: monitoring and current status.

Williams DL, Gillis TP.

Lepr Rev. 2012 Sep;83(3):269-81. Review. No abstract available.

PMID:
23356028
11.
12.

Advances and hurdles on the way toward a leprosy vaccine.

Duthie MS, Gillis TP, Reed SG.

Hum Vaccin. 2011 Nov;7(11):1172-83. doi: 10.4161/hv.7.11.16848. Epub 2011 Nov 1. Review.

13.

Probable zoonotic leprosy in the southern United States.

Truman RW, Singh P, Sharma R, Busso P, Rougemont J, Paniz-Mondolfi A, Kapopoulou A, Brisse S, Scollard DM, Gillis TP, Cole ST.

N Engl J Med. 2011 Apr 28;364(17):1626-33. doi: 10.1056/NEJMoa1010536.

14.

Hansen's disease (leprosy) complicated by secondary mycobacterial infection.

Scollard DM, Stryjewska BM, Prestigiacomo JF, Gillis TP, Waguespack-Labiche J.

J Am Acad Dermatol. 2011 Mar;64(3):593-6. doi: 10.1016/j.jaad.2009.10.004. Epub 2010 May 21. Review.

PMID:
20494478
15.

Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.

Raman VS, O'Donnell J, Bailor HR, Goto W, Lahiri R, Gillis TP, Reed SG, Duthie MS.

Infect Immun. 2009 Dec;77(12):5623-30. doi: 10.1128/IAI.00508-09. Epub 2009 Sep 28.

16.

Implications of high level pseudogene transcription in Mycobacterium leprae.

Williams DL, Slayden RA, Amin A, Martinez AN, Pittman TL, Mira A, Mitra A, Nagaraja V, Morrison NE, Moraes M, Gillis TP.

BMC Genomics. 2009 Aug 25;10:397. doi: 10.1186/1471-2164-10-397.

17.

Enumeration of Mycobacterium leprae using real-time PCR.

Truman RW, Andrews PK, Robbins NY, Adams LB, Krahenbuhl JL, Gillis TP.

PLoS Negl Trop Dis. 2008;2(11):e328. doi: 10.1371/journal.pntd.0000328. Epub 2008 Nov 4.

18.

Expression and characterization of recombinant interferon gamma (IFN-gamma) from the nine-banded armadillo (Dasypus novemcinctus) and its effect on Mycobacterium leprae-infected macrophages.

Peña MT, Adams JE, Adams LB, Gillis TP, Williams DL, Spencer JS, Krahenbuhl JL, Truman RW.

Cytokine. 2008 Aug;43(2):124-31. doi: 10.1016/j.cyto.2008.04.014. Epub 2008 Jun 16.

19.

Transmission of leprosy: a study of skin and nasal secretions of household contacts of leprosy patients using PCR.

Job CK, Jayakumar J, Kearney M, Gillis TP.

Am J Trop Med Hyg. 2008 Mar;78(3):518-21.

PMID:
18337353
20.

Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.

Sousa AL, Stefani MM, Pereira GA, Costa MB, Rebello PF, Gomes MK, Narahashi K, Gillis TP, Krahenbuhl JL, Martelli CM.

Am J Trop Med Hyg. 2007 Nov;77(5):829-33.

PMID:
17984336
21.

Antigen-specific cellular and humoral responses are induced by intradermal Mycobacterium leprae infection of the mouse ear.

Duthie MS, Reece ST, Lahiri R, Goto W, Raman VS, Kaplan J, Ireton GC, Bertholet S, Gillis TP, Krahenbuhl JL, Reed SG.

Infect Immun. 2007 Nov;75(11):5290-7. Epub 2007 Aug 27.

22.

Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases.

Scollard DM, Joyce MP, Gillis TP.

Clin Infect Dis. 2006 Jul 15;43(2):e19-22. Epub 2006 Jun 9.

PMID:
16779736
23.

The continuing challenges of leprosy.

Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL.

Clin Microbiol Rev. 2006 Apr;19(2):338-81. Review.

24.

Expression of nine-banded armadillo (Dasypus novemcinctus) interleukin-2 in E. coli.

Adams JE, Peña MT, Gillis TP, Williams DL, Adams LB, Truman RW.

Cytokine. 2005 Dec 7;32(5):219-25. Epub 2005 Dec 9.

PMID:
16338142
25.

Biological implications of Mycobacterium leprae gene expression during infection.

Williams DL, Torrero M, Wheeler PR, Truman RW, Yoder M, Morrison N, Bishai WR, Gillis TP.

J Mol Microbiol Biotechnol. 2004;8(1):58-72.

PMID:
15741741
26.

Molecular detection of drug resistance in Mycobacterium leprae.

Williams DL, Gillis TP.

Lepr Rev. 2004 Jun;75(2):118-30. Review. No abstract available.

PMID:
15282962
27.

In situ type 1 cytokine gene expression and mechanisms associated with early leprosy progression.

Stefani MM, Martelli CM, Gillis TP, Krahenbuhl JL; Brazilian Leprosy Study Group.

J Infect Dis. 2003 Oct 1;188(7):1024-31. Epub 2003 Sep 16.

PMID:
14513423
28.

Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis.

Williams DL, Pittman TL, Gillis TP, Matsuoka M, Kashiwabara Y.

J Clin Microbiol. 2001 Jun;39(6):2083-8.

29.

Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.

Martelli CM, Stefani MM, Gomes MK, Rebello PF, Peninni S, Narahashi K, Maroclo AL, Costa MB, Silva SA, Sacchetim SC, Nery JA, Salles AM, Gillis TP, Krahenbuhl JL, Andrade AL.

Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):247-57.

PMID:
11221086
30.

Dapsone resistance in Mycobacterium leprae.

Gillis TP, Williams DL.

Lepr Rev. 2000 Dec;71 Suppl:S91-5.

PMID:
11201896
31.

Mycobacterium leprae typing by genomic diversity and global distribution of genotypes.

Matsuoka M, Maeda S, Kai M, Nakata N, Chae GT, Gillis TP, Kobayashi K, Izumi S, Kashiwabara Y.

Int J Lepr Other Mycobact Dis. 2000 Jun;68(2):121-8.

PMID:
11036491
32.

The effect of ultraviolet light radiation on Mycobacterium leprae.

Truman RW, Gillis TP.

Int J Lepr Other Mycobact Dis. 2000 Mar;68(1):11-7.

PMID:
10834064
33.

Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance.

Williams DL, Spring L, Harris E, Roche P, Gillis TP.

Antimicrob Agents Chemother. 2000 Jun;44(6):1530-7. Erratum in: Antimicrob Agents Chemother 2001 Feb;45(2):647.

34.

Detection of drug-resistant Mycobacterium leprae using molecular methods.

Williams DL, Gillis TP.

Indian J Lepr. 1999 Jan-Mar;71(1):137-53. Review. No abstract available.

PMID:
10439334
35.
36.

Report of workshop on new tools for diagnosis and epidemiology.

Gillis TP, Cho SN.

Int J Lepr Other Mycobact Dis. 1998 Dec;66(4):594-5. No abstract available.

PMID:
10347586
37.

Potential application of molecular biology to leprosy research.

Gillis TP.

Int J Lepr Other Mycobact Dis. 1998 Dec;66(4):591-2. No abstract available.

PMID:
10347585
38.

[Potential applications of molecular biology to leprosy research].

Gillis TP.

Acta Leprol. 1999;11(2):43-4. French. No abstract available.

PMID:
19785196
39.

Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.

Williams DL, Spring L, Collins L, Miller LP, Heifets LB, Gangadharam PR, Gillis TP.

Antimicrob Agents Chemother. 1998 Jul;42(7):1853-7.

40.

Impaired responses to Mycobacterium leprae antigens in rhesus monkeys experimentally inoculated with simian immunodeficiency virus and M. leprae.

Gormus BJ, Murphey-Corb M, Martin LN, Baskin GB, Mack PA, Xu K, Ratteree MS, Gerone PJ, Scollard DM, Gillis TP.

Lepr Rev. 1998 Mar;69(1):24-39.

PMID:
9628093
41.
43.

Role of polymerase chain reaction in the diagnosis of early leprosy.

Job CK, Jayakumar J, Williams DL, Gillis TP.

Int J Lepr Other Mycobact Dis. 1997 Dec;65(4):461-4.

PMID:
9465155
44.
46.

Ethanol fixation of sputum sediments for DNA-based detection of Mycobacterium tuberculosis.

Williams DL, Gillis TP, Dupree WG.

J Clin Microbiol. 1995 Jun;33(6):1558-61.

47.

Characterization of rifampin-resistance in pathogenic mycobacteria.

Williams DL, Waguespack C, Eisenach K, Crawford JT, Portaels F, Salfinger M, Nolan CM, Abe C, Sticht-Groh V, Gillis TP.

Antimicrob Agents Chemother. 1994 Oct;38(10):2380-6.

48.

Clinical trial of fusidic acid for lepromatous leprosy.

Franzblau SG, Chan GP, Garcia-Ignacio BG, Chavez VE, Livelo JB, Jimenez CL, Parrilla ML, Calvo RF, Williams DL, Gillis TP.

Antimicrob Agents Chemother. 1994 Jul;38(7):1651-4.

49.

Effects of fixation on polymerase chain reaction detection of Mycobacterium leprae.

Fiallo P, Williams DL, Chan GP, Gillis TP.

J Clin Microbiol. 1992 Dec;30(12):3095-8.

50.

Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR.

Williams DL, Gillis TP, Fiallo P, Job CK, Gelber RH, Hill C, Izumi S.

Mol Cell Probes. 1992 Oct;6(5):401-10.

PMID:
1474978

Supplemental Content

Loading ...
Support Center